Imperial College London
Portrait Picture

DrNikhilVergis

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

n.vergis

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Vergis:2019:10.1016/j.jhep.2019.01.016,
author = {Vergis, N and Atkinson, S and Thursz, M},
doi = {10.1016/j.jhep.2019.01.016},
journal = {Journal of Hepatology},
pages = {785--787},
title = {The future of therapy for alcoholic hepatitis - beyond corticosteroids},
url = {http://dx.doi.org/10.1016/j.jhep.2019.01.016},
volume = {70},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Corticosteroids are the only treatment proven to reduce mortality from severe alcoholic hepatitis (SAH), though the benefit is short-lived.1 Several potential therapies are currently under evaluation in human clinical trials (Table 1). These therapies target: i) malnutrition; ii) intestinal dysbiosis and its portal translocation; iii) bile acid production; iv) hepatocyte death; v) hepatocyte regeneration; and vi) life-threatening complications of the disease itself.
AU  - Vergis,N
AU  - Atkinson,S
AU  - Thursz,M
DO  - 10.1016/j.jhep.2019.01.016
EP  - 787
PY  - 2019///
SN  - 0168-8278
SP  - 785
TI  - The future of therapy for alcoholic hepatitis - beyond corticosteroids
T2  - Journal of Hepatology
UR  - http://dx.doi.org/10.1016/j.jhep.2019.01.016
UR  - http://hdl.handle.net/10044/1/67117
VL  - 70
ER  -
Download